专利号:US-12146136-B2 优先权日:2020-03-26 标题:Synthesis of modified oligonucleotides with increased stability 发明人:KHVOROVA ANASTASIA; ROUX LOÃ?C MAURICE RENÉ JEAN; YAMADA KEN 权利人:UNIV MASSACHUSETTS 摘要:This disclosure relates to the synthesis of novel modified oligonucleotides. The synthesis of novel phosphoramidites are also provided.
专利号:US-6069250-A 优先权日:1995-12-14 标 题 :Method and compositions for the synthesis of dioxolane nucleosides with β-configuration 发明人:MANSOUR TAREK; CIMPOIA ALEX; BEDNARSKI KRZYSZTOF 权利人:IAF BIOCHEM INT 摘要:The present invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. In particular, this invention relates to the stereoselective synthesis of the beta (cis) isomer by glycosylating the base with an intermediate of formula (II) below a temperature of about -10 DEG C. wherein R1 and L are as defined herein.
专利号:US-2023078498-A1 优先权日:2020-02-07 标题 :Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis 发明人:ANDERSON DOUGLAS MATTHEW 权利人:UNIV ROCHESTER 摘要:The present disclosure provides proteins, nucleic acids, systems and methods for enhancing the synthesis of a protein.
专利号:US-2005080260-A1 优先权日:2003-04-22 标 题 :Preparation of prodrugs for selective drug delivery 发明人:MILLS RANDELL L; WU GUO-ZHANG 摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.
专利号:US-10378035-B2 优先权日:2015-04-22 标 题 :Synthesis of transcripts using Syn5 RNA polymerase 发明人:ZHU BIN; RICHARDSON CHARLES C; TABOR STANLEY 权利人:HARVARD COLLEGE 摘要:Methods of in vitro transcription using cyanophage Syn5 RNA polymerase (RNAP) or mutants thereof and transcription conditions are provided.
专利号:US-9796978-B1 优先权日:2002-02-01 标 题:Oligonucleotide compositions with enhanced efficiency 发明人:WOOLF TOD; TAYLOR MARGARET 权利人:LIFE TECHNOLOGIES CORP 摘要:The oligonucleotide compositions of the present invention make use of combinations of oligonucleotides. In one aspect, the invention features an oligonucleotide composition including at least 2 different oligonucleotides targeted to a target gene. This invention also provides methods of inhibiting protein synthesis in a cell and methods of identifying oligonucleotide compositions that inhibit synthesis of a protein in a cell.
[参考文献]: Goodman Mg, Weigle Wo. Intracellular Lymphocyte Activation And Carrier-Mediated Transport Of C8-Substituted Guanine Ribonucleosides. Proc Natl Acad Sci U S A. 1984 Feb;81(3):862-6. [参考文献]: Koo Gc, Jewell Me, Manyak Cl, Sigal Nh, Wicker Ls. Activation Of Murine Natural Killer Cells And Macrophages By 8-Bromoguanosine. J Immunol. 1988 May 1;140(9):3249-52. [参考文献]: Yajima R, Et Al. A Conformationally Restricted Guanosine Analog Reveals The Catalytic Relevance Of Three Structures Of An Rna Enzyme. Chem Biol. 2007 Jan;14(1):23-30.